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M
ental retardation (MR) occurs in 2–3% of the general
population, and more than half of MR patients are
categorised as idiopathic—that is, the cause is
unknown.1 2 Patients with idiopathic MR are presumed to
be affected with certain genetic disorders or undetectable
chromosomal abnormalities. MR may also be caused by
environmental factors independently or by their interaction
with genetic factors. Subtelomeric rearrangements comprise
about half of segmental aneusomies,3 and are one of the
major causes of MR.4 5 A recent review showed that
subtelomeric rearrangements were detected in 131 (5.1%)
of 2585 children with MR.1 4–6 Conventional cytogenetic
analysis can detect many, but not all, rearrangements,
depending on its powers of resolution.4 Other methods, such
as fluorescent in situ hybridisation (FISH) using a complete
set of subtelomeric probes, multicolour FISH (M-FISH),
comparative genomic hybridisation (CGH), spectrum karyo-
typing, multiple amplifiable probe hybridisation, primed in
situ labelling, and genotyping have been designed to detect
subtelomeric rearrangements, but none of them is ideal in
terms of sensitivity and/or efficiency.4 6 Microarray based
CGH is a promising, high throughput method of detecting
subtelomeric rearrangements.4 Veltman et al recently reported
a microarray CGH system using crude bacterial/plasmid
derived artificial chromosome (BAC/PAC) DNA for the
analysis of subtelomeric aberrations, and suggested that
degenerate oligonucleotide primed (DOP)-PCR products
could also be used instead of crude clone DNA, although
the performance of DOP-PCR products might be less
sensitive.7 We have developed a microarray CGH system to
identify rearrangements involving a subtelomeric region,
using DOP-PCR that amplifies subtelomeric BAC/PAC DNA.
Here we describe details of the method and the results of
microarray CGH analyses of five cases of Wolf-Hirschhorn
syndrome (WHS) associated with terminal 4p deletions as
positive controls, and of 69 patients with idiopathic MR with
or without multiple congenital anomalies (MCA).
MATERIALS AND METHODS
Target DNA for microarray
BAC/PAC clones used in this study are shown in table 1. We
selected subtelomeric clones based on the second generation
set of human chromosome specific subtelomeric probes
reported by Knight et al.8 Five clones (GS-124I4 for 16p,
GS-48O23 and GS-325I23 for 19q, GS-82O2 for 20p, and GS-
202M24 for Xq) that showed signals appearing at sites
different from those originally reported were excluded from
this study. Three clones (GS-99K24, CITD-3018K1 for 22q,
and GS-225F6 for XqYq) were unavailable. New clones
(RP11-359B7 for 19q, RP11-238J15 for 20p, RP3-402G11 for
22q, and RP11-431N21 for XqYq) were obtained from online
databases, the human telomere mapping and sequencing
project (http://www.wistar.upenn.edu/Riethman/) and the
human genome browser (http://genome.ucsc.edu/cgi-bin/
hgGateway? Db = hg11). Although RP11-431N21 mapped
to Xq/Yq showed unequal signal intensities between Xq and
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Abbreviations: ANILFR, average normalised inter-locus fluorescence
ratio; BAC, bacterial artificial chromosome; CGH, comparative genomic
hybridisation; DOP, degenerate oligonucleotide primed; FISH,
fluorescent in situ hybridisation; M-FISH, multicolour FISH; MR, mental
retardation; PAC, plasmid derived artificial chromosome; WHS, Wolf-
Hirschhorn syndrome
Key points
N We have developed a microarray based comparative
genomic hybridisation (CGH) assay using bacterial
and plasmid derived artificial chromosome clones
mapped uniquely to each subtelomeric region of
human chromosomes.
N To confirm the reliability of detecting cryptic subtelo-
meric rearrangements, we analysed five cases of Wolf-
Hirschhorn syndrome (WHS) that were known to have
a distal 4p deletion. The microarray CGH system
successfully enabled us to reveal that two of the five
WHS cases had 5q or 10q trisomy in addition to the 4p
deletions present in all.
N We then analysed 69 subjects with idiopathic mental
retardation (MR), whose karyotype was normal by
conventional G banding analysis. The microarray
successfully disclosed cryptic subtelomeric rearrange-
ments in 4 (5.8 %) of the 69 patients.
N All these abnormalities showed a fluorescent signal
intensity ratio (Cy3/Cy5) beyond the 2SD range, and
were subsequently confirmed by conventional fluores-
cent in situ hybridisation using subtelomere specific
BAC/PAC clones. Their karyotypes were ish
dup(12)(p13.3p13.3)mat; ish del(9)(q34.3)de novo;
ish der(5) t (5;20) (p15.33;p13)pat ; and ish
der(10)t(10;12)(q26.3;p13).
N The microarray CGH we have developed is a rapid
and high throughput system and provides a promising
way to find subtelomeric rearrangements in patients
with idiopathic MR or MCA of unknown cause.
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Yq (FISH signals of Xq were twice as intense as those of Yq),
we included it in our microarray because no other suitable
clones could be obtained. In addition, we added two X
chromosome specific clones (RP11-267O9 on Xp22.32 and
RP4-617A9 on Xp22.3) as internal controls. Clones were
purchased from either Incyte Genomics (Polo Alto, CA, USA)
or Invitrogen (Carlsbad, CA, USA). DNA was extracted using
QIAgen Plasmid Midi kits (QIAgen, Hilden, Germany) from
200 ml bacterial culture with appropriate antibiotics accord-
ing to the manufacturer’s protocol.
Degenerate oligonucleotide primed PCR
DOP-PCR was performed to amplify target clone DNA using
three different 59-aminolabelled PCR primers, DOP-A (5’-
CCGACTCGAGNNNNNNATGTGG-3’), DOP-B (5’-CCGACTC
GAGNNNNNNTTCACC-3’), and DOP-C: (5’-CCGACTCGAG
NNNNNNAACAGG-3’). The sequence of DOP-A is the same
as that of 6MW by Telenius et al.9 Two other primers were
randomly designed and confirmed as capable of amplifying
clone DNAs as effectively as DOP-A. Primers were purchased
from Hokkaido System Science Co Ltd (Sapporo, Japan).
DOP-PCR was performed in a 100 ml cocktail containing
50 ng BAC/PAC DNA, 1 mmol/l of a DOP primer, 3 mmol/l
MgCl2, 200 mmol/l of each dNTP, 16 ExTaq buffer (Takara
Bio, Ohtsu, Japan), and 0.5 U ExTaqTMHS enzyme (Takara
Bio). PCR was cycled 30 times at 94 C˚ for 30 seconds, at
linear ramping of 37–72 C˚ over 10 minutes, and at 72 C˚ for
1 minute. Successfully amplified PCR products, usually 0.2–
2 kb in size, were used for subsequent experiments. Using
DOP-A, DOP-B, or DOP-C, each PCR product (100 ml) was
mixed with the same volume (300 ml) of 46print buffer
(1 mol/l sodium phosphate/0.001% N-lauroyl sarcosine,
pH 8.5) and concentrated to a final volume of 30 ml using
Microcon 100 (Millipore, Bedford, MA, USA). The products
were mixed with DMSO and ddH2O to a final concentration
of 16print buffer/20% DMSO and were ready for prints.
Subject DNA
Genomic DNA from 69 cases of idiopathic MR, whose
karyotype was normal by G banding chromosome analysis
at the 400 band level, was analysed. MCA was seen in all
subjects except one, but recognisable syndromes were ruled
out by at least one of the co-authors. We also used DNA from
five patients with WHS (WHS1–5), who had been diagnosed
as having various deletions for distal 4p, as positive controls
to examine the reliability of the microarray CGH system
described below (table 2), and that from normal controls as
reference DNA for the system.
Microarray CGH
Each product was spotted in triplicate onto CodeLinkTM
activated slides (Amersham Bioscience, Buckinghamshire,
UK) using Stampman (Nippon Laser and Electronics
Laboratory, Nagoya, Japan) with a centre to centre distance
of 1 mm between adjacent spots. The same triplicate spots
were printed twice to block A and block B on the same slide.
The slides were then pretreated,10 denatured, and stored in a
desiccator until use. Subjects’ DNA was labelled with Cy3,
and control DNA with Cy5 (CGH 1). Reverse labelling
(patient DNA with Cy5, and control DNA with Cy3) was
also performed (CGH 2). BamHI digested genomic DNA
(1 mg) was labelled with Cy5 or Cy3 dCTP by random prime
labelling. Differentially labelled DNA was mixed with 67.5 mg
CotI DNA (Invitrogen, Tokyo, Japan), and suspended with
60 ml hybridisation buffer (50% formamide, 10% dextran
sulfate, 0.1% Tween 20, 26SSC, 10 mmol/l Tris-HCl; pH 7.4)
with 60 mg yeast tRNA (Roche, Basel, Switzerland). After
prehybridisation with herring sperm DNA and human CotI
DNA using an in situ frame (Eppendorf, Hamburg, Germany)
Table 1 BAC/PAC clones used in subtelomeric
microarray CGH
Locus Clone ID Clone type
1pter GS-232B23 BAC
1qter GS-160H23 PAC
2pter GS-8L3 BAC
2qter CITB-172I13 BAC
3pter CITB-228K22 BAC
3qter GS-56H22 BAC
4pter GS-36P21 PAC
4qter GS-31J3 BAC
5pter GS-189N21 PAC
5qter GS-240G13 PAC
6pter GS-62I11 PAC
6qter GS-57H24 PAC
7pter GS-164D18 PAC
7qter GS-3K23 PAC
8pter GS-77L23 BAC
8qter GS-261I1 BAC
9pter GS-43N6 PAC
9qter GS-135I17 BAC
10pter GS-306F7 PAC
10qter GS-137E24 PAC
11pter GS-44H16 PAC
11qter GS-26N8 PAC
12pter GS-124K20 BAC
12qter GS-221K18 PAC
13qter GS-163C9 PAC
14qter GS-200D12 PAC
15qter GS-154P1 PAC
16pter CITB-191K2 BAC
16qter GS-240G10 PAC
17pter GS-68F18 BAC
17qter GS-50C4 BAC
18pter GS-52M11 P1
18qter GS-75F20 BAC
19pter CITB-129F16 BAC
19qter RP11-359B7 BAC
20pter RP11-530N10 BAC
20qter RP11-238J15 BAC
21qter GS-63H24 PAC
22qter RP3-402G11 PAC
XpterYpter GS-98C4 PAC
XqterYqter RP11-431N21 BAC
Xp22.32 RP11-267O9 BAC
Xp22.3 RP4-617A9 BAC
RP11-267O9 and RP4-617A9 cover the steroid sulphatase
gene (STS) and the arylsulfatase E gene (ARSE), respectively.
Table 2 Summary of chromosomal aberrations detected
in this study
Patient Previous karyotype
Confirmed karyotype
by combined results of
microarray CGH and FISH
WHS
WHS1 46,XY,del(4)(p16)de
novo
46,XY.ish der(4)t(4;10)
(p16;q26)de novo
WHS2 46,XY del(4)(p16) 46,XY,der(4)t(4;5)
(p15.3;q35.1)pat
WHS3 46,XX,del(4)(p16.1).ish
del(4)(p16.3)(D4S96-)
Same as above
WHS4 46,XY,del(4)(p15.3) Same as above
WHS5 46,XX,del(4)(p15.2)de
novo
Same as above
MR
N02R245 Normal 46,XX.ish dup(12)
(p13.33p13.33)mat
N03R003 Normal 46,XY.ish del(9)(q34.3)de novo
N03R017 Normal 46,XY.ish der(5)t(5;20)
(p15.33;p13)pat
N03R088 Normal 46,XX,der(10)t(10;12)
(q26.3;p13.1)
WHS, Wolf-Hirschhorn syndrome; MR, mental retardation.
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surrounding each block on a slide in a hybridisation chamber
(Genetix, New Milton, UK), labelled probe mixtures of CGH1
and CGH2 were simultaneously applied to blocks A and B,
respectively. Slides were incubated at 37 C˚ for 72 hours with
gentle shaking (5 rpm), and then washed twice with solution
A (16PBS with 0.05% Tween 20) for 10 minutes at room
temperature, twice with solution B (26SSC with 50%
formamide) at 43 C˚ for 15 minutes, and finally with solution
A at room temperature for 10 minutes. Slides were scanned
with GenePix 4000B (Axon Instruments Inc, Union City, CA,
USA) and analysed with GenePix Pro 4.0 software (Axon
Instruments Inc).
The intensity ratio between patient and control DNA was
calculated from the data of the single slide experiment, using
the ratio of means formula. Average normalised inter-locus
fluorescence ratio (ANILFR)11 was calculated for each CGH.
We had previously performed five sets of CGH experiments
with two different normal DNA samples in order to evaluate
the thresholds for copy number gain and loss, which showed
that the average ANILFR of each clone ranged from 0.86 to
1.18, with an SD of 0.06. Based on this, the normal ANILFR
range was defined as numbers within 2SD. This configura-
tion was verified by the fact that the ANILFR of all clones
excluding unique X chromosomal clones were within 2SD
(fig 1A). If the mean signal ratio on each spot of clone was
more than 2SD out of range, FISH analysis was subsequently
performed.
FISH analysis
Subtelomeric BAC/PAC DNA labelled with either
SpectrumOrangeTM dUTP or SpectrumGreenTM dUTP (Vysis,
Downers Grove, IL, USA) by nick translation was used for
FISH analysis. Probes were denatured and hybridised to
metaphase chromosomes of patients at 37 C˚ for 16 hours and
washed. Photoimages were captured using a monochrome
CCD camera (Carl Zeiss, Jena, Germany) on an Axioplan 2
fluorescence microscope (Carl Zeiss) with appropriate filters,
and were analysed with ISIS software (version 3.4.5;
MetaSystems, Altlussheim, Germany). All five WHS cases
were analysed using all subtelomeric clones to confirm the
results of the microarray analysis. In MR patients, specific
subtelomeric probes were used for FISH analysis where a
deletion or a duplication was suspected.
RESULTS
Patients with WHS
Five cases of WHS were analysed as positive controls by
microarray CGH and FISH using all subtelomeric probes. As
expected, using microarray CGH with the 4p subtelomeric
clone, GS-36P21, the signal ratios for the patients were
beyond the 2SD range (fig 1B–F), and all were confirmed to
have a deletion at the GS-36P21 site. In addition, other
subtelomeric aberrations were suspected by microarray
analysis—that is, a 10q duplication in WHS1 and a 5q
duplication in WHS2 (fig 1B, C). FISH using respective
subtelomeric clones confirmed these aberrations. The parents
of WHS1 and the mother of WHS2 were normal by FISH
studies, but the father of WHS2 had a balanced translocation
between 4p and 5q. High resolution G banding analysis
indicated his karyotype to be 46,XY,t(4;5)(p15.3;q35.1).
Thus, the karyotypes of WHS1 and 2 were interpreted
as 46,XY.ish der(4)t(4;10)(p16;q26)de novo and
Figure 1 Microarray CGH profiles in
a normal control and five cases of
WHS. (A), (B), (C), (D), (E), and (F)
indicate microarray CGH profiles in a
normal male and in WHS1, 2, 3, 4,
and 5, respectively. Horizontal axis, left
to right: subtelomeric clones mapped to
1p, 1q, 2p, 2q, 3p, 3q, 4p, 4q, 5p, 5q,
6p, 6q, 7p, 7q, 8p, 8q, 9p, 9q, 10p,
10q, 11p, 11q, 12p, 12q, 13q, 14q,
15q, 16p, 16q, 17p, 17q, 18p, 18q,
19p, 19q, 20p, 20q, 21q, 22q, Xp/Yp,
Xq/Yq, and clones covering STS at
Xp22.32 and ARSE at Xp22.3. Vertical
axis showed the CGH ratio (Cy5/Cy3)
at each locus. CGH1 was performed by
hybridisation of Cy3 labelled test DNA
(patient) and Cy5 labelled reference
DNA (normal control of opposite sex).
CGH2 was hybridised with Cy5
labelled test DNA (patient) and Cy3
labelled reference DNA (normal control
of opposite sex). Chromosomal gains
and losses found were shown as blue
and red characters, respectively. All
rearrangements were clearly detected
as ratios beyond the 2SD range. All
WHS cases clearly showed their
terminal 4p deletions (B–F). WHS1 and
2 also showed subtelomeric
duplications of 10q and 5q,
respectively (B, C). Internal reference
clones in the X chromosome were also
indicated as ratios beyond the 2SD
range because of being the opposite
sex.
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46,XY,der(4)t(4;5)(p15.3;q35.1)pat, respectively (table 2). In
order to verify the accuracy of these micorarray CGH data, all
subtelomeric regions were investigated by FISH in the five
WHS cases, which confirmed the CGH data and supported
the reliability of the method (table 2).
Idiopathic MR patients
We analysed 69 cases of idiopathic MR with or without MCA
by microarray CGH. Subtelomeric rearrangements were
detected in the following four cases (5.8%): N02R245,
N03R003, N03R017, and N03R088 (table 2).
N02R245
A 2 year old girl was the second child of non-consanguineous
healthy parents without any family history of MR or
congenital anomalies. Her birth at 38 gestational weeks was
uneventful, with a birthweight of 3130 g (+0.3 SD), length of
50 cm (+1SD) and Apgar score of 9 at 5 minutes. She showed
moderate developmental delay. She could control her head at
5 months of age, and sit at 10 months, but could neither
walk nor speak any meaningful words at 19 months. At the
age of 21 months, her height was 80 cm (25th percentile),
weight 9.6 kg (25th percentile), and head circumference
49 cm (90th percentile). Minor facial anomalies noted
included epicanthal fold, depressed nose, low nasal bridge,
and thin upper lip. A brain MRI study at 10 months did not
reveal any abnormalities. A chromosomal gain of a 12p
subtelomeric region was detected by microarray CGH (fig 2A).
FISH analysis on metaphase chromosomes using the 12p
subtelomeric clone GS-124K20 revealed that a signal on one
homologous chromosome 12 was twice as large as that on the
other (fig 3A), and duplicated signals and a separate single
signal were detected on interphase cells (fig 3A), suggesting
that tandem duplication of a 12p subtelomeric region had
occurred. A similar finding was observed in her mother,
whose phenotype was normal, but it was not observed in her
father. High resolution G banding analysis of the patient and
her mother did not reveal any differences in chromosome 12
(fig 4A). In order to see whether the 12p duplication was a
normal variant, FISH analysis using GS-124K20 as the probe
was performed on 50 normal Japanese controls, none of
which showed the duplication.
N03R003
An 8 year old boy had severe MR, seizures, microcephaly,
dysmorphic face, and other anomalies. Detailed clinical
information has been described elsewhere as patient 2.12
Chromosomal deletion of a 9q subtelomeric region was
detected by micorarray CGH (fig 2B), and was confirmed by
FISH using a 9q subtelomeric probe as described previously12
(fig 3B). As FISH analysis confirmed that neither of his
parents had such a deletion, it was considered a de novo
mutation. G banding chromosome analysis could not identify
the deletion in the patient (fig 4B).
N03R017
A 15 month old boy was the first child of non-consanguin-
eous healthy parents without any family history of MR or
congenital anomaly. His birth at 39 gestational weeks was
uneventful. His birth weight was 3046 g (+0.25 SD), birth
length 52 cm (+1.5 SD), and Apgar score 9 at 5 minutes. He
presented with severe developmental delay. He could control
his head at 5 months of age, and sit at 12 months, but could
neither walk nor speak any meaningful words at
14.5 months old. At 1 year of age, his height was 75 cm
(50th percentile), and weight 7.8 kg (3rd percentile). Minor
craniofacial anomalies were microcephaly, flat occiput,
epicanthal folds, depressed nasal root, long philtrum, low
set ears, and micrognathia. Infantile leukaemia was observed
at the age of 10 months, and chemotherapy was performed.
A subtelomeric chromosomal deletion of 5p and a gain of 20p
were detected by microarray CGH (fig 2C), and were
confirmed by FISH (fig 3C). FISH analysis of his parents
revealed that his phenotypically normal father showed a
balanced translocation between 5p and 20p, but no morpho-
logical difference between homologous chromosomes 5 and
20 was observed by G banding analysis (fig 4C).
N03R088
A 6 year old girl was born at 41 gestational weeks
uneventfully. Her birth weight was 3020 g (21 SD), birth
Figure 2 Microarray CGH in
idiopathic MR cases. (A), (B), (C), and
(D) show the results of microarray CGH
on N02R245, N03R003, N03R017,
and N03R088, respectively.
Chromosomal gains and losses
identified are shown as blue and red
characters, respectively. Abnormal
rearrangements were clearly detected
as a CGH ratio beyond the 2SD range
of ANILFR. (A) Duplication of 12p; (B)
deletion of 9q; (C) deletion of 5p and
duplication of 20p; (D) deletion of 10q
and duplication of 12p.
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length 47 cm (21.5 SD), and Apgar score 9/10 at 1 and
5 minutes. She was the second child of non-consanguineous
healthy parents. She showed general hypotonia and severe
developmental delay. She could control her head at 6 months
of age, roll over at 9 months, and sit at 4 years, but could
neither walk nor speak any meaningful words at 6 years of
age. She had febrile seizures that occurred at 1 year of age,
but never developed epilepsy. Craniofacial abnormalities
were noted: flat occiput, square shaped face, hypertelorism,
low set ears, downturned corners of the mouth, cleft soft
palate, and micrognathia. Brain MRI revealed mild dilatation
of the lateral ventricles, cavum septum pellucidi, and cavum
vergae. A sacral dimple was identified, but MRI could not
reveal any gross abnormalities. Microarray CGH analysis
detected a subtelomeric chromosomal deletion of 10q and a
gain of 12p (fig 2D), which were subsequently verified by
FISH (fig 3D). High resolution G banding analysis revealed
that her karyotype was 46,XX,der(10)t(10;12)(q26.3;p13.1)
(fig 4D). A parental origin of the unbalanced transloca-
tion was not confirmed because parental materials were
unavailable.
DISCUSSION
Molecular studies focusing on cryptic subtelomeric rearrange-
ments in idiopathic MR patients have been performed
mainly by FISH using subtelomere specific probes, and
genotyping using hypervariable genetic markers.1 4–6
Microarray CGH, a high throughput technology, was devel-
oped to identify changes in copy number of chromosomal
segments or genes not only in somatic events (neoplasms),
but also in germline derived events (constitutional chromo-
somal changes).13–18 Recently, Veltman et al showed the
efficiency of subtelomere specific microarray CGH in detect-
ing known and novel cytogenetic abnormalities.7 We have
developed subtelomere specific microarray CGH for MR. Its
accuracy has been confirmed using five cases of WHS as
positive controls, and we applied it to analysis of 69 patients
with idiopathic MR. All the WHS cases showed a 4p
subtelomeric deletion, and two were found to have either a
10q or a 5q duplication by microarray CGH. Four (5.8 %) of
69 cases of idiopathic MR were found to have subtelomeric
rearrangements, the frequency being consistent with the data
from recent reports.1 4–6 The accuracy of our microarray CGH
was verified by FISH using all subtelomeric probes in the five
WHS cases; the genomic rearrangements were not over-
looked by our microarray CGH in any of them. ANILFR of
clones with either a deletion or a duplication, and in those
without changes of the copy number were 0.628, 1.433, and
0.995, respectively, in all the patients. The two former ratios
were beyond the 2SD range, while all other clones were
within the range (figs 1 and 2). We used three different DOP-
PCR primers, DOP-A (the original primer developed by
Telenius et al and named as 6MW9), DOP-B, and DOP-C
(both originally designed by us). DOP-PCR products using
these primers should represent original clones more faithfully
than those using a single DOP primer. Similarly, Fiegler et al10
adopted DOP-PCR using three different primers designed to
amplify human specific DNA instead of contaminated
bacterial DNA, and showed efficient detection of gains and
deletions in a cancer cell line. Although our primers, DOP-B
and DOP-C, were not designed for human specific DNA,
DOP-PCR using the three primers was suitable for generating
DNA for microarray. In addition, using the two simultaneous,
independent hybridisations, CGH1 and CGH2, on one glass
slide can eliminate conflicting results due to different
conditions in each hybridisation, and detect genomic gains
and deletions easily, because the data complement each
other.
As well as the common 4p deletion, additional chromoso-
mal abnormalities were detected in two (WHS1 and 2) of five
WHS patients. Both showed a typical WHS phenotype,
suggesting that the WHS critical region could be the
‘‘master’’ regulatory sequence on clinical manifestations with
a strong pleiotropic effect,19 or that the effects of 10q26
duplication and 5q35.3 duplication could be minimal.
Cryptic subtelomeric rearrangements were detected in 4 of
the 69 cases of idiopathic MR (table 2). A 9q34.3 terminal
Figure 3 FISH studies confirming
chromosomal abnormalities that were
detected by micorarray CGH in
idiopathic MR cases. (A), (B), (C), and
(D) show the results of the FISH analysis
to confirm the microarray CGH
detected rearrangements. (A) A
subtelomeric clone for 12p (GS-
124K20; green) was hybridised to
metaphase chromosomes from
N02R245. The arrow and arrowhead
indicate a signal of a normal
chromosome and that of its counterpart
chromosome with a duplication,
respectively. (B) A 9q subtelomeric
clone (GS-135I17; green) was
hybridised to chromosomes of
N03R003. The arrow indicates a signal
on chromosome 9, and the arrowhead
shows a deletion. (C) Subtelomeric
clone of 5p (GS-189N21; green) and
subtelomeric clone for 20p (RP11-
530N21; orange) were hybridised to
chromosomes of N03R017. The arrow-
head indicates a derivative chromosome,
ish der(5)t(5;20)(p15.33;p13)pat. (D)
Subtelomeric clones for 10q (GS-
137E24; green) and for 12p (GS-
124K20; orange) were hybridised to
chromosomes of N03R088. The arrow-
head indicates a derivative chromosome,
der(10)t(10;12)(q26.3;p13.1).
134 Letter to JMG
www.jmedgenet.com
 group.bmj.com on February 9, 2012 - Published by jmg.bmj.comDownloaded from 
deletion was found in N03R003. This, together with the 4p
terminal deletions identified in three WHS (WHS3, 4, and 5),
might have originated from hidden unbalanced transloca-
tions that our microarray system could not detect. If so,
breakpoints might exist distal to the subtelomeric clones that
were used in microarray CGH. However, as each subtelomeric
clone is located within 500 kb of the chromosomal end, a
phenotypic effect of a hidden duplication derived from the
unbalanced translocation may be subtle. A tandem duplica-
tion (ish dup(12)(p13.33p13.33)mat) detected in N02R245
may be a normal variant, because her phenotypically normal
mother had the same abnormality, but we could not detect
this duplication among 50 normal Japanese controls. Further
FISH analysis using other BAC clones mapped at 12p13.33
showed that the duplicated region was mapped to a region
0–530 kb proximal to the 12p telomeric end according to the
UCSC genome browser (data not shown), but the orientation
(inverted or directed) of the tandem duplication was
uncertain. Two unbalanced translocations, ish der(5)t(5;20)
(p15.33;p13)pat in N03R017 and der(10)t(10;12)(q26.3;p13.1)
in N03R088, were detected. The origin of the latter
remained unknown because parental materials were not
available. The 5p subtelomeric deletion in N03R017 merits
comment; a BAC clone covering CTNND2 encoding delta-2
catenin associated with the critical deleted region of cri du
chat syndrome (CdCS)20 was not deleted in this patient
(Okamoto, in preparation), supporting the absence of any
CdCS phenotypes and indicating that the 5p deletion was less
than 1.1 Mb distance from the 5p telomere. In N03R088, who
had a 10q26.3 deletion, a triangular face was not observed as
previously reported.21 A five item checklist was proposed by
de Vries et al to improve the detection rate of subtelomeric
rearrangements in MR subjects.22 Retrospective scoring using
the checklist revealed that the mean score in our 69 cases was
5.8, and scores in N02R245, N03R003, N03R017, and
N03R088, who had subtelomeric rearrangements, were 2, 6,
6, and 6, respectively. These figures support the previous
findings, which showed that a score of 3 or higher had a
sensitivity of 100% with rather low specificity of 27% and was
therefore recommended as the cut off point.22 Several types of
chromosomal aberrations were recently reported to be related
to the olfactory receptor (OR) gene clusters at 8p23 and 4p16.
A common inversion polymorphism between two of these
clusters at 8p23 exists in the normal population, and mothers
heterozygous for the inversion may have a risk of bearing
children with a complex rearrangement, inv dup del(8p).23 24
A similar inversion between two OR clusters at 4p16 has also
been found.25 Mothers with double heterozygous inversions
at 8p23 and 4p16 tend to have an increased risk of
t(4;8)(p16;p23) in their offspring,25 and children with
der(4)t(4;8)(p16;p23) may suffer from WHS owing to distal
4p deletions.26–28 However no such translocation was found in
our cases. To detect all submicroscopic chromosomal
abnormalities, construction of a high resolution genomic
microarray covering the whole genome is required.13 14 16
Buckley et al reported a full coverage microarray for
Figure 4 Partial karyotypes of
rearranged chromosomes detected in
MR cases. (A), (B), (C), and (D) show G
banded partial karyotypes of
N02R245, N03R003, the father of
N03R017, and N03R088, respectively.
(A–C) No morphological changes were
noted between homologous chromo-
somes; (D) an unbalanced translocation,
der(10)t(10;12)(q26.3;p13.1), was
recognised by high resolution G
banding analysis. The arrow indicates
a 10q26.3 breakpoint.
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chromosome 22 facilitating successful detection of genomic
aberrations in acral melanoma, dermatofibrosarcoma,
DiGeorge syndrome, and neurofibromatosis type 2.17 We are
now developing a high resolution microarray system that
covers the whole human genome and are planning to identify
genes responsible for genetic disorders including MR and MR
related syndromes as research bases. In the near future, such
microarrays targeting the whole genome including subtelo-
meric regions may be used in clinical diagnosis.
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